Form 4: UNH Director Timothy Flynn Acquires Deferred Stock Units
Insider Transaction Report
UnitedHealth Group Director Timothy Flynn acquired 272 deferred stock units as part of his quarterly compensation, increasing his direct beneficial ownership.
Summary
- Timothy Patrick Flynn, a Director of UnitedHealth Group Inc. (UNH), acquired 272 shares of Common Stock.
- These shares represent deferred stock units granted as regular quarterly compensation for his service as a director.
- The deferred stock units are immediately vested but must be retained until the director's completion of service on the Board.
- The transaction occurred on October 1, 2025, with a reported price of $0 per unit.
- Following this transaction, Mr. Flynn directly beneficially owns 9,810 shares and indirectly owns 6,033 shares through a Trust.
Sentiment
Score: 7
Explanation: The transaction is a routine grant of deferred stock units as director compensation, which aligns the director's interests with shareholders and is generally viewed positively as a standard governance practice.
Positives
- Director Timothy Flynn received 272 deferred stock units as part of his regular quarterly compensation, aligning his interests with shareholders.
- The deferred stock units are immediately vested, providing immediate ownership rights, albeit with a retention requirement.
- The acquisition increases Mr. Flynn's direct beneficial ownership in UnitedHealth Group to 9,810 shares, demonstrating continued commitment.
Future Outlook
NA
Industry Context
This transaction represents a routine insider filing for director compensation, common across publicly traded companies, and does not inherently reflect broader industry trends beyond standard corporate governance and compensation practices.
Comparison to Industry Standards
- The grant of deferred stock units as part of director compensation is a common practice among large-cap companies like UnitedHealth Group, aligning director incentives with long-term shareholder value.
- The immediate vesting with a retention requirement until service completion is also a standard feature in many such plans, comparable to practices at peer healthcare and insurance conglomerates.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation Policy Implementation | Grant of 272 deferred stock units (DSUs) to Director Timothy Patrick Flynn as regular quarterly compensation for service on the Board. These DSUs are immediately vested but require retention until the director's completion of service. | 2025-10-01 | Reinforces alignment of director interests with long-term shareholder value by linking compensation to equity and mandating retention, promoting sustained commitment. |
Related Party Transactions
- Timothy Patrick Flynn, a Director of UnitedHealth Group, received 272 deferred stock units as part of his regular quarterly compensation for service on the Board. This transaction is between the company and a director, constituting a related party transaction.
Stakeholder Impact
- Shareholders: Increased alignment of director interests with shareholder value due to increased equity ownership and retention requirements.
- Director (Timothy Patrick Flynn): Received compensation in the form of equity, subject to retention until service completion.
Key Dates
| Date | Description |
|---|---|
| 2025-10-01 | Date of transaction for the acquisition of deferred stock units. |
| 2025-10-03 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing details a routine grant of deferred stock units to a director as part of their compensation. While it increases insider ownership, it does not provide new fundamental information that would warrant a change in investment recommendation. It is a standard corporate governance practice that aligns director interests with shareholders, thus maintaining a 'hold' recommendation based solely on this filing.
Keywords
UNH, UnitedHealth Group, Timothy Flynn, Form 4, Director, Deferred Stock Units, Insider Transaction, Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.